Skip to main content

Table 3 Endotypes and outcomes on ICU admission

From: Defining critical illness using immunological endotypes in patients with and without sepsis: a cohort study

Variable

Septic (N = 377)

Non-septic (N = 145)

Adaptive (N = 151)a

Coagulopathic (N = 97)a

Inflammopathic (N = 129)a

p valueb

Adaptive (N = 74)a

Coagulopathic (N = 48)a

Inflammopathic (N = 23)a

p valueb

Secondary infection

30 (19.9%)

36 (37.1%)

48 (37.2%)

 < 0.01

4 (5.4%)

2 (4.2%)

6 (26.1%)

 < 0.01

CCI

40 (26.5%)

38 (39.2%)

44 (34.1%)

0.1

2 (2.7%)

2 (4.2%)

6 (26.1%)

 < 0.01

Adverse outcome

63 (41.7%)

63 (65.6%)

87 (67.4%)

 < 0.001

18 (24.7%)

10 (20.8%)

12 (52.2%)

0.02

 Missing

0

1

0

 

1

0

0

 

Poor discharge disposition

49 (32.5%)

42 (43.8%)

61 (47.3%)

0.03

12 (16.4%)

7 (14.6%)

4 (17.4%)

0.95

 Missing

0

1

0

 

1

0

0

 

In-hospital mortality

7 (4.6%)

6 (6.2%)

15 (11.6%)

0.07

2 (2.7%)

1 (2.1%)

0 (0%)

 > 0.99

30-day mortality

11 (7.4%)

9 (9.5%)

18 (14%)

0.19

4 (5.4%)

1 (2.1%)

1 (4.4%)

0.74

 Missing

2

2

0

     

90-day mortality

22 (15.2%)

16 (17%)

23 (18.4%)

0.78

5 (6.8%)

2 (4.2%)

1 (4.4%)

0.89

 Missing

6

3

4

     

IMX-SEV severity risk band

   

 < 0.001

   

 < 0.001

 Low

38 (25.2%)

0 (0%)

0 (0.00%)

 

15 (20.3%)

1 (2.1%)

0 (0%)

 

 Moderate

113 (74.8%)

72 (74.2%)

65 (50.4%)

 

59 (79.7%)

47 (97.9%)

18 (78.3%)

 

 High

0 (0.0%)

25 (25.8%)

64 (49.6%)

 

0 (0%)

0 (0%)

5 (21.7%)

 
  1. CCI chronic critical illness, adverse outcome is defined as cumulative incidence of in-hospital, 30-, and 90-day mortality, development of CCI, and poor discharge disposition
  2. aMean (SD); n (%)
  3. bKruskal-Wallis rank sum test; Pearson's Chi-squared test; Fisher's exact test